Eli Lilly And Co Company Profile

✉ Email this page to a colleague

ELI LILLY AND CO has seven approved drugs.

There are nineteen US patents protecting ELI LILLY AND CO drugs. There is one tentative approval on ELI LILLY AND CO drugs.

There are three hundred and eighty-two patent family members on ELI LILLY AND CO drugs in fifty-six countries and forty-four supplementary protection certificates in eighteen countries.

International Patents:	382
US Patents:	19
Tradenames:	10
Ingredients:	6
NDAs:	7
Drug Master File Entries:	37
Patent Litigation for Eli Lilly And Co:	See patent lawsuits for Eli Lilly And Co
PTAB Cases with Eli Lilly And Co as petitioner:	See PTAB cases with Eli Lilly And Co as petitioner
PTAB Cases with Eli Lilly And Co as patent owner:	See PTAB cases with Eli Lilly And Co as patent owner

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eli Lilly And Co	OLUMIANT	baricitinib	TABLET;ORAL	207924-001	May 31, 2018		RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Eli Lilly And Co	AXIRON	testosterone	SOLUTION, METERED;TRANSDERMAL	022504-001	Nov 23, 2010		DISCN	Yes	No	9,180,194	⤷ Subscribe				⤷ Subscribe
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806-004	Nov 8, 2023		RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Eli Lilly And Co	AXIRON	testosterone	SOLUTION, METERED;TRANSDERMAL	022504-001	Nov 23, 2010		DISCN	Yes	No	8,807,861	⤷ Subscribe	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-003	Jun 15, 1999	4,626,549*PED	⤷ Subscribe
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-001	Dec 29, 1987	6,960,577	⤷ Subscribe
Eli Lilly And Co	REYVOW	lasmiditan succinate	TABLET;ORAL	211280-002	Jan 31, 2020	8,748,459	⤷ Subscribe
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-001	Dec 29, 1987	4,035,511	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	30 mg/1.5 mL	➤ Subscribe	2013-01-29

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
Serbia	59146	⤷ Subscribe
Eurasian Patent Organization	201892057	⤷ Subscribe
Australia	2020310852	⤷ Subscribe
South Africa	200904568	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2379528	300969	Netherlands	⤷ Subscribe	PRODUCT NAME: ABEMACICLIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/18/1307 20181001
2379528	PA2019004	Lithuania	⤷ Subscribe	PRODUCT NAME: ABEMACIKLIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/18/1307 20180927
2288610	C20170022 00232	Estonia	⤷ Subscribe	PRODUCT NAME: BARITSITINIIB;REG NO/DATE: EU/1/16/1170 15.02.2017
2288610	1790035-8	Sweden	⤷ Subscribe	PRODUCT NAME: BARICITINIB; REG. NO/DATE: EU/1/16/1170 20170215
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.